Advisor Group Holdings, Inc. V Tv Therapeutics Inc. Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.42 - $0.75 $814 - $1,455	1,940 Added 94.17%	4,000 $1,000
Q3 2021 Nov 05, 2021	SELL	$1.53 - $2.22 $2,295 - $3,330	-1,500 Reduced 42.13%	2,060 $3,000
Q2 2021 Aug 02, 2021	BUY	$2.27 - $3.44 $3,541 - $5,366	1,560 Added 78.0%	3,560 $8,000
Q1 2020 May 18, 2020	BUY	$1.63 - $3.75 $3,260 - $7,500	2,000 New	2,000 $4,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.